Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Encephalitis l: Introduction

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

Cerebral Edema ll: Pathophysiology

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...

Brain Abscess l: Introduction

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...

Epilepsy and Seizures: Overview

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comprehensive genotype-phenotype analysis in POLR3-related disorders.

HGG advances·2025

Same author

BRAT1-Associated Leukodystrophy Exacerbated by Classic Hodgkin Lymphoma-Directed Therapy.

The neurologist·2023

Same author

Beta-Mannosidosis Is a Cause of Hypomyelination.

Pediatric neurology·2023

Same author

Stable Leukoencephalopathy in a Patient With <i>ACTA2</i>-Associated Multisystem Smooth Muscle Disorder.

Neurology·2022

Same author

Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3.

American journal of medical genetics. Part A·2021

Same author

Biallelic variants in KARS1 are associated with neurodevelopmental disorders and hearing loss recapitulated by the knockout zebrafish.

Genetics in medicine : official journal of the American College of Medical Genetics·2021

Search research articles

Related Experiment Video

Updated: May 23, 2026

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Clinical approach to leukoencephalopathies.

Deborah L Renaud¹

¹Division of Child and Adolescent Neurology, Department of Neurology, Mayo Clinic, 200 First St. SW, Rochester, MN 55901, USA. renaud.deborah@mayo.edu

Seminars in Neurology

|April 24, 2012

Summary

New genetic discoveries aid leukoencephalopathy diagnosis, yet many patients remain undiagnosed. This article outlines a systematic clinical and MRI-based approach to guide testing strategies for better patient evaluation.

More Related Videos

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice

Published on: January 2, 2013

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Related Experiment Videos

Last Updated: May 23, 2026

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice

Published on: January 2, 2013

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Area of Science:

Biochemistry
Molecular Genetics
Neurology

Background:

Recent advances in biochemical and molecular genetics have identified novel leukoencephalopathies.
A significant number of patients with leukoencephalopathy continue to be diagnosed despite these advancements.
There is a need for a structured methodology to investigate these patients effectively.

Purpose of the Study:

To present a systematic approach for evaluating patients with leukoencephalopathy.
To guide the selection of appropriate diagnostic testing strategies.
To integrate clinical and magnetic resonance imaging (MRI) findings for comprehensive assessment.

Main Methods:

A clinical evaluation framework for leukoencephalopathy patients.
Utilization of magnetic resonance imaging (MRI) findings in diagnosis.
A systematic approach to patient investigation and testing selection.

Main Results:

The proposed approach facilitates a structured investigation of leukoencephalopathy.
It aids in identifying the most suitable diagnostic tests for individual patients.
Integration of clinical and MRI data enhances diagnostic accuracy.

Conclusions:

A systematic, MRI-based clinical approach is crucial for diagnosing leukoencephalopathy.
This strategy helps in managing undiagnosed cases effectively.
Optimized testing strategies improve patient outcomes in leukoencephalopathy.